ID   P4G9
AC   CVCL_A8U7
DR   ATCC; HB-10213
DR   DSHB; P4G9
DR   Wikidata; Q102114727
RX   Patent=US5730978;
RX   PubMed=1691191;
RX   PubMed=2527858;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10213.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13612; Human ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 5
//
RX   Patent=US5730978;
RA   Wayner E.A.;
RT   "Inhibition of lymphocyte adherence with alpha4beta1-specific
RT   antibodies.";
RL   Patent number US5730978, 24-Mar-1998.
//
RX   PubMed=1691191; DOI=10.1083/jcb.110.4.1387;
RA   Carter W.G., Wayner E.A., Bouchard T.S., Kaur P.;
RT   "The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell
RT   and cell-substrate adhesion of human epidermal cells.";
RL   J. Cell Biol. 110:1387-1404(1990).
//
RX   PubMed=2527858; DOI=10.1083/jcb.109.3.1321;
RA   Wayner E.A., Garcia-Pardo A., Humphries M.J., McDonald J.A.,
RA   Carter W.G.;
RT   "Identification and characterization of the T lymphocyte adhesion
RT   receptor for an alternative cell attachment domain (CS-1) in plasma
RT   fibronectin.";
RL   J. Cell Biol. 109:1321-1330(1989).
//